Efficacy of intraoperative low-dose remimazolam as a third antiemetic agent for preventing early postoperative nausea in high-risk patient: A Randomized controlled trial
Abstract Background Postoperative nausea and vomiting (PONV) is one of the most common and distressing side effects of general anesthesia. According to the Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, patients at high risk of PONV should be given at least thre...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-09-01
|
| Edice: | BMC Anesthesiology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12871-025-03332-3 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
